- Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. Ingle, J.N., Suman, V.J., Mailliard, J.A., Kugler, J.W., Krook, J.E., Michalak, J.C., Pisansky, T.M., Wold, L.E., Donohue, J.H., Goetz, M.P., Perez, E.A. Breast Cancer Res. Treat. (2006)